Home Science Health FDA says YES to Botox for chronic migraines

On October 15, 2010, the U.S. Food and Drug Administration (FDA) approved the use of Botox for chronic migraine headaches.

The 10-15-2010 FDA press release 'FDA approves Botox to treat chronic migraine' states 'The U.S. Food and Drug Administration today approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine is defined as having a history of migraine and experiencing a headache on most days of the month.'

Dr. Russell Katz, who is the director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research, is quoted in the press release.

Dr. Katz says, 'Chronic migraine is one of the most disabling forms of headache. Patients with chronic migraine experience a headache more than 14 days of the month. This condition can greatly affect family, work, and social life, so it is important to have a variety of effective treatment options available.'

The health-care company Allergan Inc., headquartered in Irvine, Calif manufactures Botox, the anti-wrinkle injection medicine.

Botox is best known for treating wrinkles.

For that use, the Allergan web site describes Botox (onabotulinurmtoxinA) as ''¦ a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in people 18 to 65 years of age for a short period of time (temporary).'

The Mayo Clinic describes Botox as: 'Botox is a well-known brand name for a medicinal form of botulinum toxin type A, also known as onabotulinumtoxinA. The toxin is produced by a specific bacterium that causes the food poisoning botulism. When injected in small doses into specific muscles, Botox doesn't poison you but acts as a muscle relaxant with effects that can last for several months.'

Read more of the Mayo Clinic article at 'Botox injections.'



Are you looking to find the most efficient IT Monitoring tool available?

IT Monitoring is an essential part of the operations of any organisation with a significant network architecture.

Multiple IT monitoring platforms are available on the market today, supporting the various needs of small, medium-sized, and large enterprises, as well as managed service providers (MSPs).

This new report studies and compares eight different IT monitoring products in terms of functionality, operations, and usability on the same server platform with 100 end devices.

Which product is easiest to deploy, has the best maintenance mode capabilities, the best mobile access and custom reporting, dynamic thresholds setting, and enhanced discovery capabilities?

Download your free report to find out.


William Atkins

William Atkins completed educational degrees in science (bachelor’s in physics and mathematics) from Illinois State University (Normal, United States) and business (master’s in entrepreneurship and bachelor’s in industrial relations) from Western Illinois University